Thyrocare Technologies Share Price

The company released the standalone financial results for the second quarter of the financial year spanning 2018-2019. The unaudited results indicate the following:

1. The total income of the company for the quarter was Rs.98.93 crore. This was an increase over the total income earned in the previous quarter at Rs.92.17 crore.
2. The total expenses incurred by the company over the quarter increased from Rs.53.24 in the first quarter to Rs.58.50 crore.
3. The total profit for the period was Rs.26.52 crore while it was Rs.25.38 crore over the previous quarter.
4. The basic and diluted earnings per share increased from Rs.4.72 at the close of the preceding quarter to Rs.4.94 and Rs.4.92 respectively at the close of the second quarter.

Q1 Results FY19

The company released the unaudited standalone financial results for the first quarter of the financial year spanning 2018-2019 and the results indicate the following:

1. The total income of the company over the quarter was Rs.92.17 crore. This was a decrease from the total income earned by the company over the previous quarter, pegged at Rs.101.58 crore.
2. The total expenses of the company over the course of the quarter was Rs.53.24 crore while it was Rs.58.06 crore at the close of the final quarter of FY18.
3. The total profit for the first quarter of FY19 was Rs.25.38 crore while it was Rs.27.64 crore over the previous quarter.
4. The basic and diluted earnings per share decreased from Rs.5.15 and Rs.5.12 respectively over the previous quarter to Rs.4.72 for the first quarter of FY19.

Annual Report 2017-2018

The company released the standalone financial results for the year ending March 2018 and the audited results indicate the following:

1. The total income of the company for the year was Rs.355.42 crore. This was an increase from the total income earned over the previous year at Rs.308.93 crore.
2. The total expenses incurred by the company over the year was, in total, Rs.205.27 crore. This was an increase from Rs.194.75 crore incurred in expenses over the preceding year.
3. The profit for the entire year was Rs.96.03 crore. This was an increase from the preceding year when it was Rs.46.67 crore.
4. The basic and diluted earnings per share at the close of FY17 were both Rs.8.69 while they were Rs.17.91 and Rs.17.85 respectively at the close of FY18.

Q4 Results FY18

The company released the financial statement of audited results for the fourth and final quarter of the financial year spanning 2017-2018 and this indicated the following:

1. The total income earned by the company was Rs.101.58 crore. This was an increase over the total income earned over the previous quarter, pegged at Rs.81.94 crore.
2. The total expenses incurred by the company over the quarter was found to be Rs.58.05 crore. This was Rs.47.25 crore over the previous quarter.
3. The profit for the quarter was Rs.27.66 crore while it was Rs.21.75 crore over the previous quarter.
4. The basic and diluted earnings per share over the course of the previous quarter were Rs.4.08 and Rs.4.07 respectively. This was Rs.5.12 at the close of the final quarter of the financial year.

Stock trends in 2018

1. The stock began trading at about Rs.698 in the beginning of the month in January 2018. It fluctuated a lot in price over the course of January 2018 but did not decrease by much.
2. February 2018 saw the stock decrease by a lot. An interim 50% dividend was announced on 15 February 2018. The stock then continued to decline over the course of the month. The final price for the month was about Rs.624.
3. The stock appeared to gain a little in March 2018 but it did not last. The final price for the month was about Rs.596.
4. The stock spiked in price in April 2018 but went down towards the close of the month. This did not however take away all the growth in April. The final price for the stock was about Rs.668 by end of April.
5. In May 2018, the stock went down in price again and the final price for the month was about Rs.611.
6. June 2018 saw the stock holding steady for a little while but declining over the course of the month to close at about Rs.574 at the end of the month.
7. The stock appeared to gain a bit in July 2018 and while there were a lot of fluctuations, the stock still closed at around Rs.623 at the end of the month.
8. The stock began at around Rs.622 in August 2018. A final 50% dividend was announced on 2 August 2018. The stock then rose to and finally closed at about Rs.650 at the end of the month.
9. In September the stock fluctuated a lot. The final price for the month was around Rs.642.
10. While the stock gained in price in October 2018, it went down by a lot over the course of the month. The final price for October 2018 was about Rs.560.
11. While the stock dipped in November 2018, it still closed a little over Rs.545 for the month.
12. In December 2018, the stock did not perform much and the final price for the month was about Rs.537.

Stock trends in 2017

1. The stock began trading at a price of about Rs.697 in January 2017. The stock decreased a little in price but gained it all back over the course of the month. An interim 50% dividend was announced on 8 February 2017. The stock then declined in price over the course of the month. In March, the stock performed well enough to reach Rs.717 in price.
2. The price of the stock peaked in April and went down over the course of the month. The final price for the month was about Rs.717.
3. While the stock did increase in price in May 2017, it went down over the course of the month. The final price for May 2017 was about Rs.715.
4. The stock did not do that well in June 2017 and went even further down in July 2017.
5. In August, a final 50% dividend was announced on 3 August 2017. The stock then declined for the rest of the month. In September, the stock did not reduce by much in price and the final price for the month was about Rs.682.
6. October 2018 saw a mild increase in prices but November 2018 saw a decrease in prices. While the stock dipped again in December, it recovered close to the end of the month to close at about Rs.699.

Stock trends in 2016

1. The stock began trading on 9 May 2016 at a rate of about Rs.618. There was a lot of fluctuation in the price but the stock rose for most of the month.
2. There was a decline in prices in June 2016. The stock then held steady for most of July 2016. The end of August saw a major increase in the price of the stocks. The final price for the month was about Rs.600.
3. A final 25% dividend was announced in September 2016 and this was done on the first day of the month. The stock was then mostly steady for the rest of the month. October 2016 marked a spike in prices while November marked a decrease in prices. But towards the close of November and throughout December 2016, the stock kept increasing in price. The final price for December 2016 was about Rs.693.
4. Should you invest in stocks of Thyrocare?
5. The company is unique in what it offers.
6. Also, the company offers round the clock service, which is beneficial for a number of people.
7. The company has franchises all over the globe.
8. It has set the record for being the first automated lab in India. It also set a record for being a laboratory that could sort vials according to barcodes automatically.
9. The company makes use of air-cargo logistics in order to ensure that samples are not delayed at any given point at any given time.
10. All of these make the company highly attractive for customers who wish to employ its services.
11. The company has also shown consistent growth over the years, making it a lucrative option for stock investments.
12. While all of these are positive, it would be best to invest in the company after performing personal research based on preferences and financial commitments.

Company information

The company was launched with an aim to perform thyroid testing for people and present them with the highest quality reports to them. As of the close of 2018, the company had over 5000 franchisees with more than 1,200 employees.

History of the company

The company was begun in the year 1996. During this time, one thyroid report cost Rs.100. The company began with 25 samples and 4 employees. The company began automating in the year 1997. In the year 2000, the company shifted to print reports and offered internet support. The years 2001 and 2002 were significant for the company with it receiving ISO and CRISIL Certifications. The company also signed with Bayer and developed its own software. The company received another certification from NABL in 2005. After this, the company marked a period of growth and automation, making it the foremost company in automatic thyroid testing.

Management

The management team of the company is led by two key individuals—Dr. A. Velumani, and Mr. A. Sundararaju. Dr. Velumani is the promoter, chairman, managing director, and chief executive officer of the company while Mr. Sundararaju serves as executive director and chief financial officer.

Thyrocare listings on NSE, BSE, and other indices

The company is listed on the BSE and NSE under the following codes:

1. BSE: 539871
2. NSE: THYROCAREEQ
3. IND: Hospitals and Medical Services
4. ISIN Code: INE594H01019
5. SECT: Pharmaceuticals and health care

The company is included in the following indices:

1. Nifty 500
2. Nifty Smallcap 250
3. S&P BSE 400 MidSmallCap Index
4. S&P BSE AllCap
5. S&P BSE MidSmallCap
6. Nifty MidSmallcap 400
7. S&P BSE 250 SmallCap Index
8. S&P BSE 500
9. S&P BSE Healthcare
10. S&P BSE SmallCap

Location

The main office is located at the following address:

D-37/1, MIDC, Turbhe, Opp. Sandoz, Navi Mumbai - 400 703

Telephone: +91 22 4125 2525 / +91 22 3090 0000

Fax: +91 22 2768 2409

Stocks vs. Mutual Funds: here's what we recommend

Stock market investments require a lot of research and knowledge. They do not generally offer any tax benefits and are regarded as high-risk investments. Hence,it is crucial to have a diversified portfolio. At Bankbazaar, we encourage our readers to invest on mutual funds.It doesn't require a lot of knowledge and equity linked mutual fund schemes offer tax benefits. Additionally, since mutual funds comprise stocks from multiple companies, they help in building a diversified portfolio.

DISCLAIMER:

The contents of this post/blog does not constitute financial or other professional advice nor does it imply in any manner a principal-agent relationship, and is not a professional advice on a specific financial matter.